How many studies have been conducted on Thrombospondin 2?

BiohacksAI has indexed 300 PubMed studies on Thrombospondin 2, including 3 randomized controlled trials (RCTs). 33% of studies involve human subjects.

What are the main research areas for Thrombospondin 2?

The primary research domains for Thrombospondin 2 are 🔬 Oncology, 🦴 Bone & Joint, ✨ Skin & Hair. This is based on analysis of 300 PubMed studies using the BiohacksAI evidence platform.

BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.

Thrombospondin 2

A thrombospondin that mediates CELL-TO-CELL INTERACTION and cell - EXTRACELLULAR MATRIX interactions. It may also function as an ANGIOGENESIS INHIBITOR through its interaction with CD36 ANTIGENS.

300+ PubMed studies analyzed · 3 RCTs · Evidence Score: 49.8

Research Domains

Thrombospondin 2 has been studied across 17 research domains including 🔬 Oncology, 🦴 Bone & Joint, ✨ Skin & Hair, 🫁 Liver & Detox, ❤️ Cardiovascular. The primary research focus is 🔬 Oncology with 31% of studies addressing this area.

Loading evidence profile...

This evidence profile for Thrombospondin 2 is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.